| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Center for Research in Reproduction and Division of Endocrinology (C.R.M., K.A.P., S.C., C.A.E., J.C.M.), Department of Internal Medicine, University of Virginia Health System, Charlottesville, Virginia 22908; Division of Reproductive Endocrinology and Infertility (R.Y., R.J.C.), Department of Reproductive Medicine, University of California, San Diego, California 92103; and Division of Endocrinology (C.M.F.), Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan 48109
Address all correspondence and requests for reprints to: Christopher R. McCartney, Center for Research in Reproduction, Box 800391, University of Virginia Health System, Charlottesville, Virginia 22908. E-mail: cm2hq{at}virginia.edu.
Context: Adolescent hyperandrogenemia is considered a forerunner of adult polycystic ovary syndrome, but its etiology remains uncertain.
Objective: Our objective was to explore the hypothesis that peripubertal obesity is associated with hyperandrogenemia.
Design and Setting: We performed a cross-sectional analysis of data obtained at General Clinical Research Centers.
Subjects: Subjects were 41 obese [body mass index (BMI) for age,
95%] and 35 normal-weight (BMI for age, <95%) peripubertal girls.
Intervention: We used pooled blood samples (
05000700 h; n = 64) while fasting or single morning (fasting) samples (n = 12).
Main Outcome Measures: We assessed adiposity and androgen concentrations.
Results: BMI correlated with total testosterone (T) (rs = 0.59), SHBG (rs = 0.69), and free T (rs = 0.69); free T was three times as great in obese girls compared with normal-weight girls (P < 0.0001 for all). BMI correlated with insulin (rs = 0.52); both insulin and LH correlated with free T (rs = 0.45 and 0.44, respectively; P < 0.001 for all). When analyzing early pubertal girls (pubertal stages 13; n = 36) alone, BMI correlated with total T (rs = 0.65), SHBG (rs = 0.74), and free T (rs = 0.75); free T was five times as great in obese early-pubertal girls (P < 0.001 for all). BMI correlated with insulin (rs = 0.65), and insulin correlated with free T (rs = 0.63, P < 0.01 for both). BMI correlated with free T while simultaneously adjusting for age, pubertal stage, insulin, LH, and dehydroepiandrosterone sulfate.
Conclusion: Peripubertal obesity is associated with marked hyperandrogenemia, which is especially pronounced in early puberty.
This article has been cited by other articles:
![]() |
D. S. Brill and S. M. Moenter Androgen Receptor Antagonism and an Insulin Sensitizer Block the Advancement of Vaginal Opening by High-Fat Diet in Mice Biol Reprod, December 1, 2009; 81(6): 1093 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Blank, C. R. McCartney, S. Chhabra, K. D. Helm, C. A. Eagleson, R. J. Chang, and J. C. Marshall Modulation of Gonadotropin-Releasing Hormone Pulse Generator Sensitivity to Progesterone Inhibition in Hyperandrogenic Adolescent Girls--Implications for Regulation of Pubertal Maturation J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2360 - 2366. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Chang Obesity and the Emergence of Sleep-Wake Gonadotropin Secretion in Girls during Early Pubertal Development J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1094 - 1096. [Full Text] [PDF] |
||||
![]() |
C. R. McCartney, K. A. Prendergast, S. K. Blank, K. D. Helm, S. Chhabra, and J. C. Marshall Maturation of Luteinizing Hormone (Gonadotropin-Releasing Hormone) Secretion across Puberty: Evidence for Altered Regulation in Obese Peripubertal Girls J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 56 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hoeger, K. Davidson, L. Kochman, T. Cherry, L. Kopin, and D. S. Guzick The Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women in Two Randomized, Placebo-Controlled Clinical Trials J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4299 - 4306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Recabarren, R. Smith, R. Rios, M. Maliqueo, B. Echiburu, E. Codner, F. Cassorla, P. Rojas, and T. Sir-Petermann Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1820 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Kent, C. L. Gnatuk, A. R. Kunselman, L. M. Demers, P. A. Lee, and R. S. Legro Hyperandrogenism and Hyperinsulinism in Children of Women with Polycystic Ovary Syndrome: A Controlled Study J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1662 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Baer, G. A. Colditz, W. C. Willett, and J. F. Dorgan Adiposity and Sex Hormones in Girls Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1880 - 1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Bloomgarden Gut Hormones, Obesity, Polycystic Ovarian Syndrome, Malignancy, and Lipodystrophy Syndromes Diabetes Care, July 1, 2007; 30(7): 1934 - 1939. [Full Text] [PDF] |
||||
![]() |
R. L. Rosenfield Identifying Children at Risk for Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 787 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. McCartney, S. K. Blank, K. A. Prendergast, S. Chhabra, C. A. Eagleson, K. D. Helm, R. Yoo, R. J. Chang, C. M. Foster, S. Caprio, et al. Obesity and Sex Steroid Changes across Puberty: Evidence for Marked Hyperandrogenemia in Pre- and Early Pubertal Obese Girls J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 430 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Titomanlio, A. Verloes, J.-C. Mercier, A. Schlegel, A. J. Polotsky, J. Rieder, N. Santoro, A. G. Hoppin, and L. M. Kaplan Case 31-2006: A Girl with Severe Obesity N. Engl. J. Med., January 11, 2007; 356(2): 194 - 196. [Full Text] [PDF] |
||||
![]() |
J. Z. Kasa-Vubu, W. Ye, K. T. Borer, A. Rosenthal, and T. Meckmongkol Twenty-Four Hour Growth Hormone and Leptin Secretion in Active Postpubertal Adolescent Girls: Impact of Fitness, Fatness, and Age at Menarche J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3935 - 3940. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bondy Endogenous sex hormones and type 2 diabetes risk. JAMA, July 12, 2006; 296(2): 169 - 169. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |